Read the article on the Convergence Lab.

Search
Close this search box.

Pfizer’s AI Approach: A Business Strategy for a Digital World

Headshot of Anastasia Christianson

At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson lists the areas at Pfizer where AI is in play and for which […]

Buildout of a Dedicated Scientific IT Office

Asian Woman seat at a desk over visual screen of Internet of Things Technology

A national government organization approached BioTeam to help them understand how the organization and the IT department could better meet scientists’ needs. They faced several challenges.

Kjiersten Fagnan on the JGI’s Genome Citation Service That Tracks Genomes Across Research

Headshot of Kjiersten Fagnan

Kjiersten Fagnan is an applied mathematician enamored of biology’s messy datasets. Now, as chief informatics officer at Lawrence Berkeley National Laboratory’s Joint Genome Institute (JGI), she finds bioinformatics’ computational and data challenges very different from applied math or partial differential equations. Fagnan is the newest guest on the Trends from the Trenches podcast, speaking with […]

Using Machine Learning to Automatically and Accurately Characterize Retinal Images

Retina at pixel scale

Automatic Characterization of Retina OCT Images To help our client with their Optical Coherence Tomography (OCT) image characterization needs, BioTeam worked with their researchers to develop an OCT segmentation software to automate the processing and segmentation of porcine retinal OCT images. BioTeam used machine learning (ML) techniques that have previously been shown to successfully segment […]

CEO Andrew Hopkins on Exscientia’s AI-Driven Approach to Modern Drug Discovery

Headshot of Andrew Hopkins

The steel industry is not a common birthplace of biotech companies, but Andrew Hopkins traces the ideas that became Exscientia back to his time there. New technologies and new processes replaced nearly 90% of the steel workforce, and Hopkins kept those market lessons. He says, “When I ended up in pharma and biotech, I had […]